Medical Equipment

Revenue of the Robotic Assisted Endovascular Systems Market Predicted to Achieve $48.94 Billion by 2030, Driven by 8.9% CAGR

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the robotic assisted endovascular systems market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Robotic Assisted Endovascular Systems Market reach by 2030 starting from 2026 levels?

The robotic assisted endovascular systems market size has demonstrated strong growth in recent years. It is forecast to increase from $32.01 billion in 2025 to $34.79 billion in 2026, at a compound annual growth rate (CAGR) of 8.7%. The historical growth of this market can be attributed to an increase in cardiovascular disease cases, growth in catheter based interventions, the expansion of interventional radiology units, a rising preference for minimally invasive surgery, and improvements in vascular imaging.

The robotic assisted endovascular systems market is projected to undergo significant expansion in the coming years, with its size expected to reach $48.94 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period is driven by factors such as an increase in robotic vascular labs, a rising demand for precision-guided interventions, the expansion of neurovascular robotic procedures, growing remote surgery capabilities, and higher hospital investments in robotic suites. Prominent trends for the forecast period include advancements in robotic catheter navigation, increased adoption in minimally invasive vascular procedures, the development of imaging-guided robotic platforms, greater utilization of remote robotic intervention, and the integration of precision vascular control systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33306&type=smp

Which Drivers Are Influencing Long-Term Growth In The Robotic Assisted Endovascular Systems Market?

The escalating occurrence of cardiovascular and neurovascular conditions is anticipated to fuel the expansion of the robotic-assisted endovascular systems market moving ahead. These diseases, which encompass ailments impacting the heart, blood vessels, and brain’s circulatory system like coronary artery disease, stroke, and cerebral aneurysms, stand as a primary contributor to global deaths and enduring incapacitation. The rise in cardiovascular and neurovascular diseases stems from an aging global populace coupled with a greater incidence of lifestyle factors such as obesity, hypertension, and physical inactivity. Robotic-assisted endovascular systems aid in addressing these conditions by facilitating extremely precise, minimally invasive navigation through blood vessels, thus enhancing the accuracy, safety, and patient outcomes for intricate vascular procedures. For example, in January 2024, data from the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the increasing occurrence of cardiovascular and neurovascular diseases is propelling the expansion of the robotic-assisted endovascular systems market.

How Is The Robotic Assisted Endovascular Systems Market Divided Into Segments?

The robotic assisted endovascular systems market covered in this report is segmented –

1) By Component: Hardware; Software; Services

2) By Product: Robotic Catheter Systems; Robotic Guidewire Systems; Robotic Angioplasty Systems; Other Products

3) By Technology: Robotic Catheter Systems; AI-Assisted Navigation Systems; Imaging-Guided Robotic Platforms; Haptic Feedback Systems; Autonomous Robotic Systems

4) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Other Applications

5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Research And Academic Institutes; Other End-Users

Subsegments:

1) By Hardware: Robotic Control Units; Robotic Catheter Systems; Navigation Consoles; Imaging Integration Modules; Surgical Instrument Arms

2) By Software: Navigation Software Platforms; Imaging Processing Software; Procedure Planning Software; Data Management Software; Clinical Decision Support Software

3) By Services: Installation Services; Maintenance And Repair Services; Training And Education Services; System Upgradation Services

How Are New Market Trends Shaping The Landscape Of The Robotic Assisted Endovascular Systems Market?

Major companies within the robotic assisted endovascular systems market are concentrating on integrating robotics with sophisticated imaging and navigation systems, such as fully remote endovascular robotic platforms. This effort aims to enhance procedural precision, facilitate complex vascular navigation, and broaden access to specialized medical care. Fully remote endovascular robotic platforms are defined as robotic systems that combine real-time fluoroscopic imaging with preoperative CT and MRI data to guide the robotic manipulation of catheters and guidewires during endovascular procedures, allowing clinicians to operate from a distant console. For instance, in October 2025, Remedy Robotics, a US-based medical technology company, launched the Remedy N1 System, an endovascular surgical robotic platform specifically designed to support fully remote neurointerventional procedures. This system, intended to improve accuracy and clinical workflow, integrates automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation, provides simultaneous robotic control of up to four endovascular devices, and includes a portable operator console with secure audiovisual connectivity to enable remote procedural execution.

Which Leading Companies Dominate The Robotic Assisted Endovascular Systems Market Share?

Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/robotic-assisted-endovascular-systems-market-report

How Does The Robotic Assisted Endovascular Systems Market Perform Across Major Global Regions?

Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Robotic Assisted Endovascular Systems Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33306&type=smp

Browse Through More Reports Similar to the Global Robotic Assisted Endovascular Systems Market 2026, By The Business Research Company

Robot Assisted Endoscope Market Report 2026

https://www.thebusinessresearchcompany.com/report/robot-assisted-endoscope-global-market-report

Robotic Surgery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/robotic-surgery-services-global-market-report

Medical Robotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-robotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795